[Management of excreta from elderly treated with antineoplastic drugs].
The excreta management of elderly patients treated by chemotherapy is not regularly dealt by a pragmatic process depending cancer treatments. It involves identifying the excreta toxicity, including their chemical classification, cytotoxic nature, renal or fecal exposition time of the drugs. Protective measures must be described to avoid the risk of contact with potentially contaminated excreta by anticancer drugs or their metabolites. To reduce the risk, information and training are essential. Medical monitoring professionals must be specific. The information must be extended to the patient and his entourage.